In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

How to select long-term dual antiplatelet therapy? Benefit and harm balance

ESC webinar on general cardiology

31/05/2018 18:00 31/05/2018 19:00 Europe/Paris How to select long-term dual antiplatelet therapy? Benefit and harm balance European Society of Cardiology contact@escardio.org DD/MM/YYYY
Acute Cardiac Care
Antiplatelet Drugs
Treatment
Acute Coronary Syndromes
Online
event

Focus on

2017 Focused update on Dual Antiplatelet Therapy (DAPT)

Learning objectives:

  • To learn the importance of ischemic and bleeding risk stratification for DAPT type and duration selection
  • To learn how to implement the currently available tools for ischemic and bleeding risk stratification
  • To learn how DAPT type and duration can be selected in clinical practice against currently available evidence
  • To learn the risks and benefits of long-term DAPT

General cardiology webinars on-demand are now exclusively CME accredited for ESC Professional & Professional Plus Members.

ESC Professional Members: Answer a few questions and get 1 CME credit